Ceruloplasmin Mediated Penile Endothelial Dysfunction in Type 1 Diabetes
Ceruloplasmin Mediated Penile Endothelial Dysfunction in Type 1 Diabetes
批准号:
7315369
负责人:
Kanchan Chitaley Schindlauer
金额:
$23.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-13 至 2009-07-31
关键词:
AcuteAgeAmericanAortaBindingBiochemicalBiological AvailabilityBlood VesselsCardiovascular systemCell membraneCeruloplasminConditionCopperDiabetes MellitusDiabetic AngiopathiesDiabetic mouseEndotheliumErectile dysfunctionFunctional disorderGelGene ExpressionGenerationsHealthcareHyperglycemiaIn VitroIncidenceInjection of therapeutic agentInsulin-Dependent Diabetes MellitusInterventionLeadLifeMeasurementMediatingMedicalMicroarray AnalysisModelingMusOryctolagus cuniculusOxidative StressPatientsPenile ErectionPhysiologicalPhysiologyPopulationPrevalencePreventionProductionProteinsPublic HealthReactive Oxygen SpeciesRelaxationReportingResourcesRiskRoleSmooth MuscleStreptozocinSuperoxidesTestingTherapeuticTimeTissuesUnited StatesVasodilationVasodilation disorderagedbasecare seekingcohortdiabeticdiabetic ratearly onsetgain of functionhealth care service utilizationimprovedin vivoin vivo Modelinsightloss of functionmenmouse modelnon-diabeticpressurepreventresponsesatisfactionsuccess
中文摘要
描述(申请人提供):糖尿病独特地影响勃起反应的所有组成部分,并且所有共病医学状况赋予ED的最大风险。在对20岁及以上OS男性的基于人群的分析中,所有糖尿病男性中有49%报告了ED。此外,糖尿病男性比无糖尿病男性利用更多的卫生保健资源用于艾德治疗,糖尿病的发病率也在增加。除了糖尿病人群中艾德患病率增加外,该队列中艾德的发病比一般人群早10-15年。这是特别相关的,因为年轻男性更有可能寻求护理和利用医疗保健资源治疗ED。因此,改善或预防男性糖尿病患者艾德的干预措施将变得越来越重要。为了检验我们的一般假设,即糖尿病患者组织特异性阴茎铜蓝蛋白表达增加导致海绵体血管舒张受损和阴茎内皮功能障碍,我们将完成以下具体目标:(1)确定铜蓝蛋白是否通过抑制eNOS活性来抑制NO生物利用度,2)确定铜蓝蛋白在体内对阴茎血管内皮功能的作用,3)研究铜蓝蛋白是否在1型糖尿病小鼠模型中引起阴茎勃起受损。与公共卫生的相关性:治疗或预防男性糖尿病患者的艾德对于提高生活满意度和减少美国人口中这一快速增长部分的卫生保健资源的利用是必要的。 与公共卫生的相关性:治疗或预防男性糖尿病患者的艾德对于提高生活满意度和减少美国人口中这一快速增长部分的卫生保健资源的利用是必要的。
英文摘要
DESCRIPTION (provided by applicant): Diabetes uniquely impacts all components of the erectile response, and all co-morbid medical conditions, imparts the greatest risk of ED. In that population based analysis of OS men aged 20 and up, 49% of all men with diabetes reported ED. Furthermore, men with diabetes utilize more health care resources for ED treatment than men without diabetes, and the incidence of diabetes if increasing. In addition to the increased prevalence of ED in the diabetic population, the onset of ED in this cohort is up to 10-15 years earlier than in the g~neral population. This is particularly relevant because younger men are more likely to seek care and utilize health care resources for the treatment of ED. Thus, interventions to improve or prevent ED in men with diabetes will become increasingly important. To test our general hypothesis that increased tissue specific penile expression of ceruloplasmin in diabetes results in impaired cavernosal vasodilation and penile endothelial dysfunction, we will complete the following specific aims: (1) determine if ceruloplasmin inhibits NO bioavailability through the inhibition of eNOS activity, 2) determine the role of ceruloplasmin on penile vascular endothelial function in vivo, 3) investigate whether ceruloplasmin causes impaired penile erection in a mouse model of type 1 diabetes. Relevance to Public Health: Treatment or prevention of ED in men with diabetes is necessary to improve life satisfaction and reduce the utilization of health care resources in this rapidly growing portion of the American population. Relevance to Public Health: Treatment or prevention of ED in men with diabetes is necessary to improve life satisfaction and reduce the utilization of health care resources in this rapidly growing portion of the American population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Disorganization of Elastin Matrix Mediates Erectile Dysfunction
-
批准号:8268132
-
项目类别:
-
资助金额:$35.39万
-
财政年份:2009
-
负责人:Kanchan Chitaley Schindlauer
-
依托单位:
Disorganization of Elastin Matrix Mediates Erectile Dysfunction
-
批准号:8425101
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2009
-
负责人:Kanchan Chitaley Schindlauer
-
依托单位:
Disorganization of Elastin Matrix Mediates Erectile Dysfunction
-
批准号:8044718
-
项目类别:
-
资助金额:$35.39万
-
财政年份:2009
-
负责人:Kanchan Chitaley Schindlauer
-
依托单位:
Disorganization of Elastin Matrix Mediates Erectile Dysfunction
-
批准号:7564910
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2009
-
负责人:Kanchan Chitaley Schindlauer
-
依托单位:
Disorganization of Elastin Matrix Mediates Erectile Dysfunction
-
批准号:7792401
-
项目类别:
-
资助金额:$39.44万
-
财政年份:2009
-
负责人:Kanchan Chitaley Schindlauer
-
依托单位:
Ceruloplasmin Mediated Penile Endothelial Dysfunction in Type 1 Diabetes
-
批准号:7485244
-
项目类别:
-
资助金额:$19.11万
-
财政年份:2007
-
负责人:Kanchan Chitaley Schindlauer
-
依托单位:
Erectile Dysfunction in Type II Diabetes: Role of Adiponectin
-
批准号:7229874
-
项目类别:
-
资助金额:$22.7万
-
财政年份:2006
-
负责人:Kanchan Chitaley Schindlauer
-
依托单位:
Erectile Dysfunction in Type II Diabetes: Role of Adiponectin
-
批准号:7020858
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2006
-
负责人:Kanchan Chitaley Schindlauer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: